382 related articles for article (PubMed ID: 8533812)
1. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.
Nishio H; Takeshima Y; Narita N; Yanagawa H; Suzuki Y; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
J Clin Invest; 1994 Sep; 94(3):1037-42. PubMed ID: 8083345
[TBL] [Abstract][Full Text] [Related]
3. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.
Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M
Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344
[TBL] [Abstract][Full Text] [Related]
4. Southern blot and PCR analyses of dystrophin gene deletions in Japanese patients with Duchenne muscular dystrophy.
Nakajima T; Matsuo M; Nakamura H; Fujiwara Y
Kobe J Med Sci; 1991 Feb; 37(1):21-33. PubMed ID: 1921260
[TBL] [Abstract][Full Text] [Related]
5. Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.
Nguyen TM; Morris GE
Am J Hum Genet; 1993 Jun; 52(6):1057-66. PubMed ID: 7684887
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies for clinical trials of Duchenne muscular dystrophy therapy.
Le TL; Nguyen TM; Morris GE
Neuromuscul Disord; 2014 Mar; 24(3):195-200. PubMed ID: 24361045
[TBL] [Abstract][Full Text] [Related]
7. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation.
Wilton SD; Johnsen RD; Pedretti JR; Laing NG
Am J Med Genet; 1993 Jun; 46(5):563-9. PubMed ID: 8322822
[TBL] [Abstract][Full Text] [Related]
8. Analysis of dystrophin gene deletions in patients from the Mexican population with Duchenne/Becker muscular dystrophy.
Coral-Vázquez R; Arenas D; Cisneros B; Peñaloza L; Kofman S; Salamanca F; Montañez C
Arch Med Res; 1993; 24(1):1-6. PubMed ID: 8292871
[TBL] [Abstract][Full Text] [Related]
9. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
Shomrat R; Gluck E; Legum C; Shiloh Y
Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
[TBL] [Abstract][Full Text] [Related]
10. [Deletion analysis of the dystrophin gene in patients with Duchenne's muscular dystrophy in Tajikistan].
Odinokova ON; Puzyrev VP; Radzhabaliev ShF; Rakhmonov RA
Genetika; 1996 Oct; 32(10):1392-5. PubMed ID: 9091412
[TBL] [Abstract][Full Text] [Related]
11. Detection of DMD gene deletions in Thai children patients.
Kamolsilp M; Paditaporn R; Noonai A; Wasant P
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():172-4. PubMed ID: 8629100
[TBL] [Abstract][Full Text] [Related]
12. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.
Gussoni E; Pavlath GK; Lanctot AM; Sharma KR; Miller RG; Steinman L; Blau HM
Nature; 1992 Apr; 356(6368):435-8. PubMed ID: 1557125
[TBL] [Abstract][Full Text] [Related]
13. Pattern of deletions of the dystrophin gene in Mexican Duchenne/Becker muscular dystrophy patients: the use of new designed primers for the analysis of the major deletion "hot spot" region.
Coral-Vazquez R; Arenas D; Cisneros B; Peñaloza L; Salamanca F; Kofman S; Mercado R; Montañez C
Am J Med Genet; 1997 Jun; 70(3):240-6. PubMed ID: 9188659
[TBL] [Abstract][Full Text] [Related]
14. [Detection of extensive deletions and duplications in the dystrophin gene].
Fajkusová L; Kuhrová V; Hájek J; Fajkus J
Cas Lek Cesk; 1997 Mar; 136(5):148-50. PubMed ID: 9221188
[TBL] [Abstract][Full Text] [Related]
15. Monitoring duchenne muscular dystrophy gene therapy with epitope-specific monoclonal antibodies.
Morris G; Man Nt; Sewry CA
Methods Mol Biol; 2011; 709():39-61. PubMed ID: 21194020
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7.
Le TT; Nguyen TM; Love DR; Helliwell TR; Davies KE; Morris GE
Am J Hum Genet; 1993 Jul; 53(1):131-9. PubMed ID: 8317478
[TBL] [Abstract][Full Text] [Related]
17. Deletion screening of the Duchenne/Becker muscular dystrophy gene in Croatian population.
Sertić J; Barisić N; Sostarko M; Brzović Z; Stavljenić-Rukavina A
Coll Antropol; 1997 Jun; 21(1):151-6. PubMed ID: 9225508
[TBL] [Abstract][Full Text] [Related]
18. [Combining approach with multiplex PCR and MLPA to detect deletion and duplication in DMD patients, carriers, and prenatal diagnosis].
Li H; Ding J; Wang W; Chen Y; Lu W; Shao H; Wu BL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):318-22. PubMed ID: 19504448
[TBL] [Abstract][Full Text] [Related]
19. Amplification of selected exons by polymerase chain reaction enables determination of the translational reading frame of dystrophin mRNA resulting from deletion mutations.
Kitoh Y; Matsuo M; Nishio H; Nakamura H
Kobe J Med Sci; 1994 Apr; 40(2):39-48. PubMed ID: 7823533
[TBL] [Abstract][Full Text] [Related]
20. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
